Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
Journal of Gastroenterology and Hepatology|February 28, 2017
Clinical utility of multipolar ablation with a 3-D simulator system for patients with liver cancerMasashi Hirooka, Yohei Koizumi, Yusuke Imai, et al.
Journal of Medical Ultrasonics (2001)|June 25, 2024
Diagnostic accuracy of ultrasound-derived fat fraction for the detection and quantification of hepatic steatosis in patients with liver biopsyYoshiko Nakamura, Masashi Hirooka, Yohei Koizumi, et al.
Clinical Journal of Gastroenterology|January 28, 2024
A case of hepatocellular carcinoma with pseudoaneurysm formation upon lenvatinib administrationRyo Yano, Masashi Hirooka, Yoshiko Nakamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 27, 2021
Measurement of multiple spleen lengths is not necessary for non-invasive prediction of high-risk esophagogastric varicesMasashi Hirooka, Takaaki Tanaka, Yohei Koizumi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 4, 2007
Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumorTsuneharu Miki, Yoichi Mizutani, Hideyuki Akaza, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2023
Clinical and Pathological Features of Immune Checkpoint Inhibitor-induced Liver Injury in Comparison with Drug-induced Liver Injury and Autoimmune HepatitisKotaro Sunago, Masanori Abe, Osamu Yoshida, et al.
Plos One|February 5, 2016
Usefulness of a New Three-Dimensional Simulator System for Radiofrequency AblationMasashi Hirooka, Yohei Koizumi, Yusuke Imai, et al.
Journal of Medical Ultrasonics (2001)|April 2, 2016
Assessment of a needle-tracking system for bipolar radiofrequency ablationMasashi Hirooka, Yohei Koizumi, Yusuke Imai, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2009
Mode of action of Van-M-02, a novel glycopeptide inhibitor of peptidoglycan synthesis, in vancomycin-resistant bacteriaKenji Miura, Hidenori Yamashiro, Kouichi Uotani, et al.
Pageof 22